SRPT
Sarepta Therapeutics Inc
NASDAQ: SRPT · HEALTHCARE · BIOTECHNOLOGY
$19.32
+2.28% today
Updated 2026-10-28
Market cap
$1.81B
P/E ratio
—
P/S ratio
0.92x
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$15 – $25
Volume
3.0M
Sarepta Therapeutics Inc (SRPT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$19.32
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.7B | $0.9B | $1.2B | $1.9B | $2.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -6.93%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.